170 related articles for article (PubMed ID: 18158152)
1. Extracellular loop 3 (ECL3) and ECL3-proximal transmembrane domains VI and VII of the mesotocin and vasotocin receptors confer differential ligand selectivity and signaling activity.
Cho HJ; Moon MJ; Kwon HB; Hwang JI; Seong JY
Gen Comp Endocrinol; 2008 Mar; 156(1):71-82. PubMed ID: 18158152
[TBL] [Abstract][Full Text] [Related]
2. Identification of amino acid residues that direct differential ligand selectivity of mammalian and nonmammalian V1a type receptors for arginine vasopressin and vasotocin. Insights into molecular coevolution of V1a type receptors and their ligands.
Acharjee S; Do-Rego JL; Oh DY; Ahn RS; Choe H; Vaudry H; Kim K; Seong JY; Kwon HB
J Biol Chem; 2004 Dec; 279(52):54445-53. PubMed ID: 15475353
[TBL] [Abstract][Full Text] [Related]
3. Molecular evolution of neuropeptide receptors with regard to maintaining high affinity to their authentic ligands.
Cho HJ; Acharjee S; Moon MJ; Oh DY; Vaudry H; Kwon HB; Seong JY
Gen Comp Endocrinol; 2007; 153(1-3):98-107. PubMed ID: 17286976
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning, pharmacological characterization, and histochemical distribution of frog vasotocin and mesotocin receptors.
Acharjee S; Do-Rego JL; Oh DY; Moon JS; Ahn RS; Lee K; Bai DG; Vaudry H; Kwon HB; Seong JY
J Mol Endocrinol; 2004 Aug; 33(1):293-313. PubMed ID: 15291760
[TBL] [Abstract][Full Text] [Related]
5. Extracellular loop 3 (EL3) and EL3-proximal transmembrane helix 7 of the mammalian type I and type II gonadotropin-releasing hormone (GnRH) receptors determine differential ligand selectivity to GnRH-I and GnRH-II.
Li JH; Choe H; Wang AF; Maiti K; Wang C; Salam A; Chun SY; Lee WK; Kim K; Kwon HB; Seong JY
Mol Pharmacol; 2005 Apr; 67(4):1099-110. PubMed ID: 15635044
[TBL] [Abstract][Full Text] [Related]
6. Identification of specific intracellular domains of the human ETA receptor required for ligand binding and signal transduction.
Hashido K; Adachi M; Gamou T; Watanabe T; Furuichi Y; Miyamoto C
Cell Mol Biol Res; 1993; 39(1):3-12. PubMed ID: 8287069
[TBL] [Abstract][Full Text] [Related]
7. Cloning, expression and pharmacological characterization of a vasopressin-related receptor in an annelid, the leech Theromyzon tessulatum.
Levoye A; Mouillac B; Rivière G; Vieau D; Salzet M; Breton C
J Endocrinol; 2005 Jan; 184(1):277-89. PubMed ID: 15642804
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning of an anuran V(2) type [Arg(8)] vasotocin receptor and mesotocin receptor: functional characterization and tissue expression in the Japanese tree frog (Hyla japonica).
Kohno S; Kamishima Y; Iguchi T
Gen Comp Endocrinol; 2003 Jul; 132(3):485-98. PubMed ID: 12849972
[TBL] [Abstract][Full Text] [Related]
9. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
[TBL] [Abstract][Full Text] [Related]
10. Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling.
Postina R; Kojro E; Fahrenholz F
Adv Exp Med Biol; 1998; 449():371-85. PubMed ID: 10026828
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of mesotocin and V1a-like vasotocin receptors in a urodele amphibian, Taricha granulosa.
Searcy BT; Bradford CS; Thompson RR; Filtz TM; Moore FL
Gen Comp Endocrinol; 2011 Jan; 170(1):131-43. PubMed ID: 20920503
[TBL] [Abstract][Full Text] [Related]
12. Amino acids in the COOH-terminal region of the oxytocin receptor third intracellular domain are important for receptor function.
Zhong M; Parish B; Murtazina DA; Ku CY; Sanborn BM
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E977-84. PubMed ID: 17148753
[TBL] [Abstract][Full Text] [Related]
13. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
[TBL] [Abstract][Full Text] [Related]
14. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.
Guillon G; Pena A; Murat B; Derick S; Trueba M; Ventura MA; Szeto HH; Wo N; Stoev S; Cheng LL; Manning M
J Pept Sci; 2006 Mar; 12(3):190-8. PubMed ID: 16130178
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the hormone-binding domain of steroid receptors using chimeras generated by homologous recombination.
Martinez ED; Pattabiraman N; Danielsen M
Exp Cell Res; 2005 Aug; 308(2):320-33. PubMed ID: 15936754
[TBL] [Abstract][Full Text] [Related]
16. Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors.
Udawela M; Christopoulos G; Tilakaratne N; Christopoulos A; Albiston A; Sexton PM
Mol Pharmacol; 2006 Jun; 69(6):1984-9. PubMed ID: 16531504
[TBL] [Abstract][Full Text] [Related]
17. Elucidation of signaling properties of vasopressin receptor-related receptor 1 by using the chimeric receptor approach.
Gupte J; Cutler G; Chen JL; Tian H
Proc Natl Acad Sci U S A; 2004 Feb; 101(6):1508-13. PubMed ID: 14757815
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of the intracellular segments of the melanocortin-4 receptor for NDP-MSH signaling.
Yang Y; Chen M; Loux TJ; Georgeson KE; Harmon CM
Biochemistry; 2005 May; 44(18):6971-9. PubMed ID: 15865442
[TBL] [Abstract][Full Text] [Related]
19. Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport.
Belville C; Maréchal JD; Pennetier S; Carmillo P; Masgrau L; Messika-Zeitoun L; Galey J; Machado G; Treton D; Gonzalès J; Picard JY; Josso N; Cate RL; di Clemente N
Hum Mol Genet; 2009 Aug; 18(16):3002-13. PubMed ID: 19457927
[TBL] [Abstract][Full Text] [Related]
20. Arginine vasotocin (AVT)/mesotocin (MT) receptors in chickens: Evidence for the possible involvement of AVT-AVPR1 signaling in the regulation of oviposition and pituitary prolactin expression.
Wu C; Lv C; Wan Y; Li X; Zhang J; Li J; Wang Y
Gen Comp Endocrinol; 2019 Sep; 281():91-104. PubMed ID: 31121165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
